Diligence memo · auto-generated · as of July 2, 2026

Lumedica Vision, Inc.

Lumedica Vision, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Lumedica Vision, Inc. operates in Other Technology, based in DURHAM.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Lumedica Vision, Inc. has raised $1.3M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $625K on 2022-11-10.

Most recent recorded round closed around 2022-11-10.

Valuation (modeled)modeled

Provath models Lumedica Vision, Inc. at approximately $7.4M (range $408K–$41M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.66× the median modeled value of Pre-Seed Other Technology companies in 2022–2024 (975 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 3.6 yr ago; this sector typically re-raises about every 13 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 4.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 33% of Other Technology peers (21302 compared).

Modeled value ranks above 18% of those peers.

Closest niche peers: InRev, Inc., Positiv.ly LLC, SmashNet INC, RealConnex Holdings Inc., Pm-Ordr, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.